发明申请
US20100150827A1 PYRIDO [2, 3-D] PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF P13K-ALPHA FOR THE TREATMENT OF CANCER
审中-公开
PYRIDO [2,3-D] PYRIMIDIN-7-ONE化合物作为P13K-ALPHA的抑制剂治疗癌症
- 专利标题: PYRIDO [2, 3-D] PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF P13K-ALPHA FOR THE TREATMENT OF CANCER
- 专利标题(中): PYRIDO [2,3-D] PYRIMIDIN-7-ONE化合物作为P13K-ALPHA的抑制剂治疗癌症
-
申请号: US12595226申请日: 2008-04-11
-
公开(公告)号: US20100150827A1公开(公告)日: 2010-06-17
- 发明人: Chris A. Buhr , William Bajjalieh , Anagha Abhijit Joshi , Katherine Lara , Sunghoon Ma , Charles K. Marlowe , Longcheng Wang , Bryan K.S. Yeung
- 申请人: Chris A. Buhr , William Bajjalieh , Anagha Abhijit Joshi , Katherine Lara , Sunghoon Ma , Charles K. Marlowe , Longcheng Wang , Bryan K.S. Yeung
- 申请人地址: US CA South San Francisco
- 专利权人: Exelixis, Inc
- 当前专利权人: Exelixis, Inc
- 当前专利权人地址: US CA South San Francisco
- 国际申请: PCT/US08/04753 WO 20080411
- 主分类号: A61K31/519
- IPC分类号: A61K31/519 ; C07D471/04 ; A61K51/00 ; A61K39/395 ; A61P35/00 ; A61P35/02
摘要:
The invention is directed to a Compound of Formula I, II, or III. The invention provides compounds that inhibit, regulate, and/or modulate PI3K that are useful in the treatment of hyperproliferatives diseases, such as cancer.